Source: Health Canada shortage reports · Updated Sep 18, 2026
Some Trimebutine products are in shortage in Canada (1 of 2 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 27, 2026.
Products affected
1 / 2
In shortage since
Sep 15, 2026
Est. full return
Nov 27, 2026
Reports on file
7
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-TRIMEBUTINE
100MG · TABLET · APOTEX INC
DIN 02245663 · since Sep 15, 2026, est. end Nov 27, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-TRIMEBUTINE
100MG · TABLET · APOTEX INC
DIN 02245663 · ended May 9, 2024 · Disruption of the manufacture of the drug.
Resolved
TRIMEBUTINE
100MG · TABLET · AA PHARMA INC
DIN 02245663 · ended Aug 9, 2023 · Disruption of the manufacture of the drug.
Resolved
TRIMEBUTINE
100MG · TABLET · AA PHARMA INC
DIN 02245663 · ended Apr 14, 2023 · Disruption of the manufacture of the drug.
Resolved
TRIMEBUTINE
100MG · TABLET · AA PHARMA INC
DIN 02245663 · ended Dec 23, 2021 · Disruption of the manufacture of the drug.
Discontinued
MODULON
200MG · TABLET · APTALIS PHARMA CANADA ULC
DIN 00803499
Resolved
MODULON
200MG · TABLET · APTALIS PHARMA CANADA ULC
DIN 00803499 · ended Jul 14, 2017 · Shortage of an inactive ingredient or component.
What's happening
Trimebutine is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Trimebutine is classified under “DRUGS FOR FUNCTIONAL BOWEL DISORDERS” (ATC A03AA).
Recent changes
Sep 18, 2026
New report filed
Common questions
When will Trimebutine be back in stock in Canada?
The latest manufacturer estimate is Nov 27, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Trimebutine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.